Literature DB >> 19539821

Cloninger's temperament traits and preclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.

Mirka Hintsanen1, Laura Pulkki-Råback, Markus Juonala, Jorma S A Viikari, Olli T Raitakari, Liisa Keltikangas-Järvinen.   

Abstract

OBJECTIVE: Cloninger's psychobiological model of temperament has recently raised interest as a risk factor for CHD. However, there are no studies that have examined the associations of Cloninger's temperament traits with atherosclerosis.
METHODS: The subjects were 398 men and 657 women (mean age 31.7 years) participating in the Cardiovascular Risk in Young Finns Study. Linear regression analyses were used to examine the cross-sectional associations between temperament traits and preclinical atherosclerosis. Preclinical atherosclerosis was measured with carotid intima-media thickness ultrasound.
RESULTS: Higher novelty seeking (NS) and reward dependence (RD) and lower harm avoidance (HA) were associated with preclinical atherosclerosis. In NS and RD, associations remained significant after adjustments for various risk factors. The effect sizes of these associations were comparable to those of traditional risk factors of coronary heart disease, which is a major finding. No association for persistence (P) was found.
CONCLUSIONS: The present findings imply that examining a wider range of temperament and personality factors may offer new information that can help in explaining the between-individual variation in atherosclerosis and CHD morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19539821     DOI: 10.1016/j.jpsychores.2009.01.002

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  12 in total

1.  Harm avoidance and risk of Alzheimer's disease.

Authors:  Robert S Wilson; Patricia A Boyle; Aron S Buchman; Lei Yu; Steven E Arnold; David A Bennett
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

2.  Cardiac stress reactivity and recovery of novelty seekers.

Authors:  Mirka Hintsanen; Sampsa Puttonen; Petrus Järvinen; Laura Pulkki-Råback; Marko Elovainio; Päivi Merjonen; Liisa Keltikangas-Järvinen
Journal:  Int J Behav Med       Date:  2009

3.  Development of Instruments and Evaluative Procedures on Contributors to Illness and Health.

Authors:  C Robert Cloninger; Kevin M Cloninger
Journal:  Int J Pers Cent Med       Date:  2011-09

4.  The dynamic origins of positive health and wellbeing.

Authors:  C Robert Cloninger; Ihsan M Salloum; Juan E Mezzich
Journal:  Int J Pers Cent Med       Date:  2012-06

5.  The positive health domain in person-centered integrative diagnosis.

Authors:  C Robert Cloninger
Journal:  Int J Integr Care       Date:  2010-01-29       Impact factor: 5.120

6.  Harm avoidance and cerebral infarction.

Authors:  Robert S Wilson; Patricia A Boyle; Steven R Levine; Lei Yu; George M Hoganson; Aron S Buchman; Julie A Schneider; David A Bennett
Journal:  Neuropsychology       Date:  2013-12-23       Impact factor: 3.295

7.  Depressive symptoms are associated with lower bone mineral density in young adults with high job strain. The Cardiovascular Risk in Young Finns Study.

Authors:  M Oikonen; M Hintsanen; M Laaksonen; V Mikkilä; M Kähönen; T Lehtimäki; L Pulkki-Råback; J S A Viikari; L Keltikangas-Järvinen; O T Raitakari
Journal:  Int J Behav Med       Date:  2014-06

8.  Temperament affects sympathetic nervous function in a normal population.

Authors:  Bora Kim; Jae-Hon Lee; Eun-Ho Kang; Bum-Hee Yu
Journal:  Psychiatry Investig       Date:  2012-09-06       Impact factor: 2.505

9.  Harm avoidance is associated with progression of parkinsonism in community-dwelling older adults: a prospective cohort study.

Authors:  Aron S Buchman; Lei Yu; Robert S Wilson; Joshua M Shulman; Patricia A Boyle; David A Bennett
Journal:  BMC Geriatr       Date:  2014-04-23       Impact factor: 3.921

10.  A genome-wide meta-analysis of association studies of Cloninger's Temperament Scales.

Authors:  S K Service; K J H Verweij; J Lahti; E Congdon; J Ekelund; M Hintsanen; K Räikkönen; T Lehtimäki; M Kähönen; E Widen; A Taanila; J Veijola; A C Heath; P A F Madden; G W Montgomery; C Sabatti; M-R Järvelin; A Palotie; O Raitakari; J Viikari; N G Martin; J G Eriksson; L Keltikangas-Järvinen; N R Wray; N B Freimer
Journal:  Transl Psychiatry       Date:  2012-05-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.